1. Home
  2. CMT vs TLSI Comparison

CMT vs TLSI Comparison

Compare CMT & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMT
  • TLSI
  • Stock Information
  • Founded
  • CMT 1996
  • TLSI 2010
  • Country
  • CMT United States
  • TLSI United States
  • Employees
  • CMT N/A
  • TLSI N/A
  • Industry
  • CMT Electronic Components
  • TLSI Medical Specialities
  • Sector
  • CMT Consumer Discretionary
  • TLSI Health Care
  • Exchange
  • CMT Nasdaq
  • TLSI Nasdaq
  • Market Cap
  • CMT 152.2M
  • TLSI 124.9M
  • IPO Year
  • CMT N/A
  • TLSI N/A
  • Fundamental
  • Price
  • CMT $16.91
  • TLSI $4.43
  • Analyst Decision
  • CMT Strong Buy
  • TLSI Strong Buy
  • Analyst Count
  • CMT 2
  • TLSI 5
  • Target Price
  • CMT $25.50
  • TLSI $12.10
  • AVG Volume (30 Days)
  • CMT 33.2K
  • TLSI 30.3K
  • Earning Date
  • CMT 11-05-2024
  • TLSI 11-14-2024
  • Dividend Yield
  • CMT N/A
  • TLSI N/A
  • EPS Growth
  • CMT N/A
  • TLSI N/A
  • EPS
  • CMT 1.75
  • TLSI N/A
  • Revenue
  • CMT $313,657,000.00
  • TLSI $26,892,000.00
  • Revenue This Year
  • CMT N/A
  • TLSI $61.76
  • Revenue Next Year
  • CMT $8.01
  • TLSI $47.30
  • P/E Ratio
  • CMT $9.30
  • TLSI N/A
  • Revenue Growth
  • CMT N/A
  • TLSI 67.92
  • 52 Week Low
  • CMT $14.64
  • TLSI $3.33
  • 52 Week High
  • CMT $21.00
  • TLSI $10.42
  • Technical
  • Relative Strength Index (RSI)
  • CMT 54.74
  • TLSI 56.00
  • Support Level
  • CMT $15.81
  • TLSI $3.74
  • Resistance Level
  • CMT $17.49
  • TLSI $4.66
  • Average True Range (ATR)
  • CMT 0.61
  • TLSI 0.36
  • MACD
  • CMT 0.05
  • TLSI 0.02
  • Stochastic Oscillator
  • CMT 75.11
  • TLSI 78.47

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Share on Social Networks: